Literature DB >> 19077730

The A2143G point mutation of clarithromycin resistance affects Helicobacter pylori eradication.

Vincenzo De Francesco, Angelo Zullo, Enzo Ierardi, Floriana Giorgio, Federico Perna, Cesare Hassan, Carmine Panella, Dino Vaira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19077730     DOI： 10.1097/MCG.0b013e318178d1e7

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN： 0192-0790            Impact factor:   3.062


× No keyword cloud information.
  3 in total

1.  Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?

Authors:  Floriana Giorgio; Mariabeatrice Principi; Vincenzo De Francesco; Angelo Zullo; Giuseppe Losurdo; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2013-08-15

2.  Helicobacter pylori Mutations Conferring Resistance to Fluoroquinolones and Clarithromycin among Dyspeptic Patients Attending a Tertiary Hospital, Tanzania.

Authors:  Hyasinta Jaka; Nele Rüttgerodt; Wolfgang Bohne; Andreas Mueller; Uwe Gross; Christa Kasang; Stephen E Mshana
Journal:  Can J Gastroenterol Hepatol       Date:  2019-07-01

3.  A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of "Geographic Weight".

Authors:  Giuseppe Losurdo; Andrea Iannone; Floriana Giorgio; Enzo Ierardi; Alfredo Di Leo; Mariabeatrice Principi
Journal:  Saudi J Gastroenterol       Date:  2016 Jan-Feb       Impact factor: 2.485
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.